These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 20940153)
1. Azithromycin in the treatment of infection with Neisseria gonorrhoeae. Bignell C; Garley J Sex Transm Infect; 2010 Nov; 86(6):422-6. PubMed ID: 20940153 [TBL] [Abstract][Full Text] [Related]
2. Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection. Bissessor M; Whiley DM; Fairley CK; Bradshaw CS; Lee DM; Snow AS; Lahra MM; Hocking JS; Chen MY Clin Infect Dis; 2015 Feb; 60(4):557-63. PubMed ID: 25371490 [TBL] [Abstract][Full Text] [Related]
3. Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada. Martin I; Sawatzky P; Liu G; Allen V; Lefebvre B; Hoang L; Drews S; Horsman G; Wylie J; Haldane D; Garceau R; Ratnam S; Wong T; Archibald C; Mulvey MR Emerg Infect Dis; 2016 Jan; 22(1):65-7. PubMed ID: 26689114 [TBL] [Abstract][Full Text] [Related]
4. An audit of pharyngeal gonorrhoea treatment in a public sexual health clinic in Adelaide, South Australia. Hustig A; Bell C; Waddell R Int J STD AIDS; 2013 May; 24(5):399-400. PubMed ID: 23970709 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of treatment with single-dose ampicillin/sulbactam with probenecid or ceftriaxone in patients with uncomplicated gonorrhea. Baddour LM; Busby L; Shapiro E; Cox KB; Glassco S; Johnson JK Sex Transm Dis; 1992; 19(6):341-5. PubMed ID: 1492262 [TBL] [Abstract][Full Text] [Related]
6. Oral cefixime versus intramuscular ceftriaxone in patients with uncomplicated gonococcal infections. Portilla I; Lutz B; Montalvo M; Mogabgab WJ Sex Transm Dis; 1992; 19(2):94-8. PubMed ID: 1534422 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of 250 mg trospectomycin sulfate i.m. vs. 250 mg ceftriaxone i.m. for treatment of uncomplicated gonorrhea. Rompalo AM; Colletta L; Caine VA; Linnemeier P; Neumann T; Hook EW; Jones RB Sex Transm Dis; 1994; 21(4):213-6. PubMed ID: 7974072 [TBL] [Abstract][Full Text] [Related]
9. Incidence and treatment outcomes of pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections in men who have sex with men: a 13-year retrospective cohort study. Ota KV; Fisman DN; Tamari IE; Smieja M; Ng LK; Jones KE; Diprima A; Richardson SE Clin Infect Dis; 2009 May; 48(9):1237-43. PubMed ID: 19323630 [TBL] [Abstract][Full Text] [Related]
10. The outcome of oropharyngeal gonorrhoea treatment with different regimens. Harry TC Int J STD AIDS; 2005 Jul; 16(7):520. PubMed ID: 16004640 [No Abstract] [Full Text] [Related]
11. Treating uncomplicated Neisseria gonorrhoeae infections: is the anatomic site of infection important? Moran JS Sex Transm Dis; 1995; 22(1):39-47. PubMed ID: 7709324 [TBL] [Abstract][Full Text] [Related]
12. [Clinic efficacy of treating chronic prostatitis caused by Neisseria gonorrhoeae with azithromycin aspartic-acid injection]. Zhou WQ; Gao JP; Sang H; Zhang ZY; Ge JP; Ma HQ; Wei W Zhonghua Nan Ke Xue; 2003 Feb; 9(1):43-4. PubMed ID: 12680331 [TBL] [Abstract][Full Text] [Related]
13. The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting. Whiley DM; Goire N; Lahra MM; Donovan B; Limnios AE; Nissen MD; Sloots TP J Antimicrob Chemother; 2012 Sep; 67(9):2059-61. PubMed ID: 22604449 [TBL] [Abstract][Full Text] [Related]
14. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Ison CA; Hussey J; Sankar KN; Evans J; Alexander S Euro Surveill; 2011 Apr; 16(14):. PubMed ID: 21492528 [TBL] [Abstract][Full Text] [Related]
15. Single dose (direct observed) azithromycin therapy for Neisseria gonorrhoeae and Chlamydia trachomatis in STD clinic attenders with genital discharge in Trinidad and Tobago. Swanston WH; Prabhakar P; Barrow L; Mahabir BS; Furlonge C West Indian Med J; 2001 Sep; 50(3):198-202. PubMed ID: 11769023 [TBL] [Abstract][Full Text] [Related]
16. Oropharyngeal gonorrhoea: rate of co-infection with sexually transmitted infection, antibiotic susceptibility and treatment outcome. Manavi K; Zafar F; Shahid H Int J STD AIDS; 2010 Feb; 21(2):138-40. PubMed ID: 19884359 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of azithromycin 1g single dose in the management of uncomplicated gonorrhoea. Habib AR; Fernando R Int J STD AIDS; 2004 Apr; 15(4):240-2. PubMed ID: 15075017 [TBL] [Abstract][Full Text] [Related]
18. Treatment of non-complicated urogenital, rectal and oropharyngeal gonorrhoea with intramuscular cefotaxime 1.0 g or cefuroxime 1.5 g. Stolz E; Ong L; van Joost T; Michel MF J Antimicrob Chemother; 1984 Sep; 14 Suppl B():295-9. PubMed ID: 6094455 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance in sexually transmitted infections in the developed world: implications for rational treatment. Ison CA Curr Opin Infect Dis; 2012 Feb; 25(1):73-8. PubMed ID: 22143116 [TBL] [Abstract][Full Text] [Related]
20. Emergence and spread of drug resistant Neisseria gonorrhoeae. Deguchi T; Nakane K; Yasuda M; Maeda S J Urol; 2010 Sep; 184(3):851-8; quiz 1235. PubMed ID: 20643433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]